Scientific Sessions 2024  /  Translating 'Almost' 100 Years of Lipoprotein Research: Current and Future Lipoprotein Interventions - Its All in the Mechanism  /  Targeting triglyceride-rich lipoproteins: Beyond fibrates and fish oils
Logo

American Heart Association

  115
  0

Final ID:

Targeting triglyceride-rich lipoproteins: Beyond fibrates and fish oils

  • Cariou, Bertrand  ( CHU Nantes , Nantes Cedex 1 , France )
  • Hobbs, Helen  ( HHMI-UT SOUTHWESTERN , Dallas , Texas , United States )
  • Boren, Jan  ( University of Gothenburg , Gothenburg , Sweden )
    • Author Disclosures:
    Bertrand Cariou: DO have relevant financial relationships ; Advisor:Novartis:Active (exists now) ; Advisor:Ultragenyx:Past (completed) ; Speaker:Amgen:Past (completed) ; Advisor:MSD:Active (exists now) ; Advisor:Eli Lilly:Active (exists now) ; Advisor:Novo-Nordisk:Active (exists now) ; Speaker:Astra-Zeneca:Past (completed) ; Speaker:Sanofi:Active (exists now) ; Research Funding (PI or named investigator):Sanofi:Past (completed) | Helen Hobbs: DO NOT have relevant financial relationships | Jan Boren: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Translating 'Almost' 100 Years of Lipoprotein Research: Current and Future Lipoprotein Interventions - Its All in the Mechanism

Sunday, 11/17/2024 , 03:30PM - 04:45PM

Cardiovascular Seminar

More abstracts on this topic:
Genetic and non-genetic influences on Lp(a) levels

Byambaa Enkhmaa, Kamstrup Pia

The future of HDL modifying therapies

Davidson William, Marsche Gunther

More abstracts from these authors:
Long-term Efficacy and Safety of Lerodalcibep in the Open-label 72-week Extension Study of Subjects Previously on Inclisiran or Lerodalcibep in the LIBerate-VI Trial

Asprusten Emil, Licka Manuela, Cariou Bertrand, Vest Jeff, Kallend David, Stein Evan

New Frontiers in Triglyceride Lowering

Tokgozoglu Lale, Remaley Alan T, Cariou Bertrand, Hudgins Lisa

You have to be authorized to contact abstract author. Please, Login
Not Available